Pinnacle Medicines
pinnaclemedicines.com
Drug Discovery AI
Drug Discovery
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$89M
1 round on record
Latest round
$89M
Series B · Mar 2026 · 7 mo ago
Team
51-200
employees, estimated range
Backers
2
RA Capital Management, Foresite Capital
The money's age
Fresh money
7 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 26
Raised a round Series B $89M
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Mar 2026 | $89M | — | br.advfn.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Superluminal Medicines is a software led drug discovery company focused on helping researchers find and develop new medicines more…
Xaira Therapeutics uses generative models for protein design and drug discovery. It launched with one of the largest initial funding rounds…
insitro applies machine learning to human genetic and cellular data for drug discovery. Its laboratory generates large datasets…
From idea to drug molecule in days™. Tell our agent your target and it will handle the rest. The first fully autonomous drug discovery…
Abzu® empowers scientists to bring drugs to market faster by accelerating their exploration and understanding. From disease understanding…
deepmirror is an AI-native drug design platform built around curated, non-public experimental molecule property measurements such as…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Foresite CapitalVia a fund
RA Capital ManagementVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Pinnacle Medicines: $89 Million Series B Raised For Oral Peptide Therapeutics Development
Pinnacle Medicines, a biotechnology company focused on oral peptide therapeutics, announced it has closed an oversubscribed $89 million Series B financing round to advance its pipeline into clinical trials. The round was co-led by LAV and Foresite Capital
Read more
Report
Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
Pinnacle Medicines ("Pinnacle" or "the Company"), a biotechnology company pioneering the development of oral peptide therapeutics using proprietary AI and physics-based platforms, today announced the closing of an oversubscribed $89 million Series B finan
Read more
Report
Financials
Total raised
$89M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2026 | $89M | Details |